mis

Hot Keywords
Non-small cell lung cancer Artificial intelligence Gastroesophageal reflux Esophagectomy Thoracic surgery Atherosclerosis Robotic surgery Gastric cancer Lung cancer Lobectomy Complications Quality of life Rectal cancer

Top
Mini-invasive Surg 2023;7:2. 10.20517/2574-1225.2022.119 © The Author(s) 2023.
Open Access Editorial

System for the safe deployment of minimally invasive pancreaticobiliary surgery in Japan

Department of Hepatobiliary-Pancreatic Surgery, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.

Correspondence to: Dr. Akio Saiura, Department of Hepatobiliary-Pancreatic Surgery, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Tokyo 113-8421, Japan. E-mail: a-saiura@juntendo.ac.jp

    Views:42 | Downloads:10 | Cited:0 | Comments:0 | :0
    Academic Editor: Giulio Belli | Copy Editor: Ke-Cui Yang | Production Editor: Ke-Cui Yang

    © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

    Abstract

    The Japanese healthcare system is characterized by universal coverage and free access. It is an excellent social system that allows everyone to receive advanced medical care at a low cost. Minimally invasive hepato-pancreato-biliary (HPB) surgery in Japan is now covered by insurance. However, after experiencing a series of serious medical accidents, Japan’s government requested a more advanced system to safely promote highly advanced surgery including laparoscopic HBP surgery. As a practical measure, the academic societies of HPB surgery established a new prospective registration system for all cases of minimally invasive HPB for highly advanced hepatobiliary and pancreatic surgery while utilizing the existing technical certification system. Under these systems, hepatobiliary and pancreatic surgeries in Japan are now being undertaken gradually but safely.

    INTRODUCTION

    Japan is one of the most aged countries in the world (considering the percentage of elderly among the population), which requires a specially prepared health system[1]. Japan’s medical care is unique in two ways. One feature is universal health insurance. While many countries have uninsured citizens, almost all citizens in Japan are covered by public health insurance. This system was developed after World War II and has greatly contributed to improving the average level of medical care in the country by providing high-quality, low-cost, safe medical care to all citizens equally. However, Japan’s aging population and economic stagnation have been increasing the economic burden on the younger generation year by year, so much so that the future sustainability of this burden is now a social problem and the topic of much debate. For example, as a result of providing supportive medical care, hospital stays after surgery are much longer in Japan compared with other countries[2].

    Another element that is creating issues in Japan’s health system is its free access, with the freedom to see any doctor at any medical institution without restrictions. From the patient’s point of view, medical care is uniform and well-established, and safe medical care is available to all. As a result, the public’s expectation for patient safety at medical institutions is very high. However, while moderate competition can improve the level of medical care at each institution, it can also lead to excessive competition among institutions, where inexperienced medical institutions are providing advanced medical care that leads to medical accidents. In Japan, medical institutions have traditionally been free to develop new medical technologies such as laparoscopic surgery. However, new medical technologies such as minimally invasive surgery, involve many risks during their development. This environment likely led to a series of serious medical accidents in HPB surgeries approximately 10 years ago, which were caused by laparoscopic surgery. Since then, a new system has been established to safely introduce and disseminate highly advanced medical technologies while respecting the autonomy of surgeons.

    MINIMALLY INVASIVE-HPB SURGERY IN JAPAN

    Yamakawa et al. performed the first minimally invasive HPB surgery in Japan in 1990 and Kaneko performed the nation’s first laparoscopic hepatectomy in 1991[3,4]. Generally, public insurance reimbursement in Japan is determined on a procedure-by-procedure basis, so new procedures are not strictly covered. At that time, an insurance refund claim was filed against a hospital that referred to laparoscopic cholecystectomy as open cholecystectomy, resulting in a major debate between academic societies and the government. This led to the realization that it is essential for the widespread use of new medical technologies such as laparoscopic surgery to be objectively evaluated for safety and effectiveness and to be covered by insurance.

    DISSEMINATION AND PUBLIC INSURANCE REIMBURSEMENT

    Public insurance reimbursement is essential not only for minimally invasive surgery but also for the wide dissemination of new medical technologies in Japan. As in other countries, new medical technologies must be objectively demonstrated to be safe and effective before they can be approved by the government for inclusion in insurance reimbursement. In Japan, treatments not included in public insurance are hence performed at the patient’s own expense, placing a financial burden on the patient or the institution. To alleviate the financial burden, the insurance covers a part of the treatment when a patient receives highly advanced medical treatment approved by the Minister of Health, Labor and Welfare of Japan. The Advanced Medical Care System (AMCS) is a partial insurance system for new medical technologies before public insurance reimbursement. The system aims to cover the cost of the treatment by evaluating its popularity, effectiveness, efficiency, safety and technological maturity based on the annual medical results. After a period of evaluation, it is determined if the procedure is suitable for public insurance reimbursement. In Japan, laparoscopic hepatectomy and pancreatectomy were included in AMCS in 2000 and 2004, respectively [Table 1]. Subsequently, laparoscopic hepatectomy was covered by public insurance in 2010. Laparoscopic resection of the pancreatic body tail and pancreaticoduodenectomy were then covered by insurance in 2012 and 2016, respectively.

    Table 1

    Public insurance reimbursement of minimally invasive HBP surgery in Japan

    YearEvents
    1990First laparoscopic cholecystectomy in Japan
    1991First laparoscopic liver resection in Japan
    1993First laparoscopic pancreatectomy in Japan
    2000Laparoscopic liver resection selected as AMCS procedure
    2004Laparoscopic pancreatectomy selected as AMCS procedure
    2010Public insurance reimbursement of laparoscopic minor hepatectomy
    2012Public insurance reimbursement of laparoscopic distal pancreaticoduodenectomy
    2016Public insurance reimbursement of laparoscopic advanced hepatectomy and laparoscopic pancreaticoduodenectomy
    2020Public insurance reimbursement of robotic-assisted pancreatectomy

    SURGEON AND INSTITUTION QUALIFICATION SYSTEM FOR HIGHLY ADVANCED HPB SURGERIES

    HPB surgery is one of the most difficult and risky gastrointestinal surgeries. In Japan, there is a system to evaluate and certify surgeons and institutions involved in HPB surgery, including minimally invasive surgery. There are two systems for evaluating individual surgeons. One is the highly skilled specialist system offered by the Japanese Society for Hepatobiliary and Pancreatic Surgery, and the other is the Endoscopic Surgical Skill Qualification System (ESSQS), a system for highly skilled specialists performing endoscopic abdominal surgery. The former is mainly for open, highly difficult hepatobiliary and pancreatic surgeries, and evaluates not only surgical skills but also comprehensive and instructive qualities as a hepatobiliary and pancreatic surgeon, including patient selection, while the latter is mainly for the evaluation of safety specific to laparoscopic surgery. However, both certifications make use of unedited videos of surgeries, which are reviewed to determine whether they are performed safely, appropriately and independently. This innovative method involving the evaluation of surgical videos contributes to the improvement of hepatobiliary and pancreatic surgery in Japan. The passing rate lies between 20% and 50%.

    The Japanese Society for Hepatobiliary and Pancreatic Surgery has also established a system to certify institutions that perform more than 30 cases of highly advanced HPB surgery per year. The Japanese national data show that advanced HPB surgeries performed at these institutions have significantly lower mortality rates[5]. These individual and institutional certification systems have made it possible to safely deploy minimally invasive surgery in HBP surgery.

    A SERIES OF SERIOUS MEDICAL ACCIDENTS IN LAPAROSCOPIC HBP SURGERY IN JAPAN

    Around 2010, a series of fatal accidents in laparoscopic HPB surgery at two leading hospitals in Japan were reported in newspapers and other media. This led to a pause in the deployment of minimally invasive HPB surgery in Japan. A third-party committee investigated the cause of the medical accidents. They concluded that inexperienced surgeons prioritized the introduction of new medical technology, and that the hospital failed to properly manage the department. These accidents illustrated the grave consequences that can be caused by an inexperienced surgeon in high-risk surgery such as HPB surgery. It resulted in a pause and set back the introduction of minimally invasive surgery, as it became widely known to the public that minimally invasive HPB surgery may be fatal if not properly introduced. New efforts were thereafter initiated by academic societies and research groups. Subsequently, to prevent the recurrence of such accidents, the national government and academic societies worked together to establish a system for the safe introduction of minimally invasive HPB surgeries. The centerpiece of this improvement program is the prospective registration of all advanced laparoscopic HBP surgeries.

    To perform these procedures safely, the government stipulated the criteria for institutions in which laparoscopic HBP surgeries can be performed, and for the correct management of patient selection and surgery in cooperation with related academic societies. Specific criteria are listed in Table 2, but there are very strict criteria regarding surgeon and institution. Patient selection and proper management of surgery are supported by registering cases in the National Clinical Database (NCD), a database of the Japanese Surgical Association; a case registration system of the Japanese Society of Hepatobiliary and Pancreatic Surgery; as well as treatment policies such as indications for surgery and postoperative management. For high-risk procedures such as laparoscopic pancreatoduodenectomy, we implemented prospective registration of clinical information and required preoperative information to be registered with the NCD at least one day before the surgery and postoperative information 90 days after the surgery date.

    Table 2

    Institutional and operator criteria for minimally invasive pancreatectomy in Japan

    OperationInstitutional criteriaOperator criteria
    LDP5 or more pancreatectomies per year
    RDP20 or more pancreatectomies per year Participation in a prospective case registry at an academic society5 or more robotic pancreatectomies as an operator. 20 or more pancreatectomies as an operator, including 5 or more cases of laparoscopic pancreatectomies
    LPD50 or more pancreatectomies, including 20 or more pancreaticoduodenectomy per year, 100 or more laparoscopic surgeries per year20 or more laparoscopic pancreatectomies as an operator

    The results of a prospective registry showed that complication and mortality rates were comparable to those of open surgery [Table 3].

    Table 3

    Operative mortality rates of all prospective case registries of laparoscopic hepatectomy and pancreatectomy in Japan 8

    OperationCasesInstitutions30-days mortality90-days mortality
    LDP1197980%0.3%
    LPD232250.4%0.4%
    LH26532780.08%0.2%

    POST-ACCIDENT DISSEMINATION AND OUTCOMES

    The results of prospective registry showed laparoscopic hepatopancreatic resection is safe and comparable to open surgery [Table 3]. The 90-day mortality rates after laparoscopic distal pancreatectomy and laparoscopic pancreaticoduodenectomy were 0.3% and 0.4%, respectively. The 90-day mortality rate after laparoscopic hepatectomy was 0.08%. Japanese NCD data show that the number of minimally invasive HPB surgery has increased dramatically over the past decade, as has been the case worldwide and in other areas of gastrointestinal surgery[6]. Ban et al. analyzed data focusing on laparoscopic liver resection, including 148,507 cases registered in the Japanese National Clinical Database between 2011 and 2017[7]. In their report, the percentage of laparoscopic liver resections without additional vascular complications or biliary reconstruction increased from 9.9% in 2011 to 24.8% in 2017. Operative mortality was 3.6% for both advanced laparoscopic liver resection and open liver resection in 2011, and decreased to 1.0% and 2.0%, respectively, in 2017. An international benchmark study of laparoscopic liver resection was recently published, which, similar to reports from other countries, demonstrated the superiority of laparoscopic surgery over open liver resection in terms of short-term outcomes such as blood loss and postoperative hospital stay[8]. Although minor hepatectomy was considered standard (IDEAL 3), major hepatectomy is still under consideration (IDEAL 2b), and is recommended to use with caution.

    In minimally invasive pancreatectomy, Ohtsuka et al. reported large-scale prospective data of laparoscopic pancreatectomy of 1429 patients[9]. The authors showed that short-term results were comparable in a propensity matching analysis of 69 centers. Nakata et al. showed that laparoscopic pancreaticoduodenectomy was safely introduced, but the number of patients has been small and only a few centers have used it, and it is currently being shifted to RPD[10]. Institutions with experience in laparoscopic distal pancreatectomy are characterized by shorter operation times, less blood loss and a lower incidence of pancreatic fistulas. Those with experience in laparoscopic pancreaticoduodenectomy had a higher rate of pure laparoscopic procedures and shorter operation times.

    Difficulty scores for laparoscopic surgery have also been developed in Japan. In 2014, Ban et al. developed difficulty scores for liver resection, and in 2018, Otsuka et al. reported difficulty scores for distal pancreatectomy[11,12]. The development of difficulty scores has contributed greatly to improving the safety of laparoscopic surgery.

    CONCLUSION

    While minimally invasive surgery offers significant benefits to patients, it also carries unique risks. We hope that the Japanese system will serve as a useful reference for the safe deployment of highly advanced minimally invasive HPB surgery.

    DECLARATIONS

    Authors’ contributions

    The author contributed solely to the article.

    Availability of data and materials

    Not applicable.

    Financial support and sponsorship

    None.

    Conflicts of interest

    The author declares that he is bound by confidentiality agreements that prevent him from disclosing his conflicts of interest in this work.

    Ethical approval and consent to participate

    Not applicable.

    Consent for publication

    Not applicable.

    Copyright

    © The Author(s) 2023.

    References

    • 1. Skirbekk V, Dieleman JL, Stonawski M, et al. The health-adjusted dependency ratio as a new global measure of the burden of ageing: a population-based study. Lancet Healthy Longev 2022;3:e332-8.

      DOIPubMed
    • 2. Mueller M, Breuer E, Mizuno T, et al. Perihilar cholangiocarcinoma - novel benchmark values for surgical and oncological outcomes from 24 expert centers. Ann Surg 2021;274:780-8.

      DOI
    • 3. Yamakawa T, Kano N, Sakai S, et al. Preliminary experience using an ultrasonic aspirator for laparoscopic cholecystectomy. Endoscopy 1992;24:721-3.

      DOIPubMed
    • 4. Kaneko H, Takagi S, Shiba T. Laparoscopic partial hepatectomy and left lateral segmentectomy: technique and results of a clinical series. Surgery 1996;120:468-75.

      DOIPubMed
    • 5. Miura F, Yamamoto M, Gotoh M, et al. Validation of the board certification system for expert surgeons (hepato-biliary-pancreatic field) using the data of the National Clinical Database of Japan: part 1 - hepatectomy of more than one segment. J Hepatobiliary Pancreat Sci 2016;23:313-23.

      DOIPubMed
    • 6. Marubashi S, Takahashi A, Kakeji Y, et al. Surgical outcomes in gastroenterological surgery in Japan: report of the National Clinical Database 2011-2019. Ann Gastroenterol Surg 2021;5:639-58.

      DOIPubMed PMC
    • 7. Ban D, Tanabe M, Kumamaru H, et al. Safe dissemination of laparoscopic liver resection in 27,146 cases between 2011 and 2017 from the National Clinical Database of Japan. Ann Surg 2021;274:1043-50.

      DOIPubMed
    • 8. Goh BKP, Han HS, Chen KH, et al. Defining global benchmarks for laparoscopic liver resections: an international multicenter study. Ann Surg ;2022:10.1097.

      DOIPubMed
    • 9. Ohtsuka T, Nagakawa Y, Toyama H, et al. A multicenter prospective registration study on laparoscopic pancreatectomy in Japan: report on the assessment of 1,429 patients. J Hepatobiliary Pancreat Sci 2020;27:47-55.

      DOIPubMed
    • 10. Nakata K, Yamamoto H, Miyata H, et al. Comparison of outcomes between laparoscopic and open pancreaticoduodenectomy without radical lymphadenectomy: results of coarsened exact matching analysis using national database systems. Asian J Endosc Surg 2022;15:15-21.

      DOIPubMed
    • 11. Ban D, Tanabe M, Ito H, et al. A novel difficulty scoring system for laparoscopic liver resection. J Hepatobiliary Pancreat Sci 2014;21:745-53.

      DOI
    • 12. Ohtsuka T, Ban D, Nakamura Y, et al. Difficulty scoring system in laparoscopic distal pancreatectomy. J Hepatobiliary Pancreat Sci 2018;25:489-97.

      DOI

    Cite This Article

    OAE Style

    Saiura A. System for the safe deployment of minimally invasive pancreaticobiliary surgery in Japan. Mini-invasive Surg 2023;7:2. http://dx.doi.org/10.20517/2574-1225.2022.119

    AMA Style

    Saiura A. System for the safe deployment of minimally invasive pancreaticobiliary surgery in Japan. Mini-invasive Surgery. 2023; 7:2. http://dx.doi.org/10.20517/2574-1225.2022.119

    Chicago/Turabian Style

    Saiura, Akio. 2023. "System for the safe deployment of minimally invasive pancreaticobiliary surgery in Japan" Mini-invasive Surgery. 7: 2. http://dx.doi.org/10.20517/2574-1225.2022.119

    ACS Style

    Saiura, A. System for the safe deployment of minimally invasive pancreaticobiliary surgery in Japan. Mini-invasive. Surg. 20237, 2. http://dx.doi.org/10.20517/2574-1225.2022.119

    Views
    42
    Downloads
    10
    Citations
     0
    Comments
    0

    0

    Comments

    Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at support@oaepublish.com.

    © 2016-2023 OAE Publishing Inc., except certain content provided by third parties